- Creso Pharma (CPH) has expanded its agreement with Route2 Pharm to allow its products to be distributed in Ecuador
- Route2 is a subsidiary of Route2Health which has over 30 years of experience producing and distributing herbal remedies and dietary supplements
- Ecuador is an ideal market to enter into as it recently passed legislation for the production and consumption of cannabis for medicinal treatment
- The Latin America and Caribbean cannabis market has 655 million users and is expected to be valued at over US$300 million (around A$391 million) by 2024
Read the Full Article on The Market Herald here
Add to My Watchlist
What is My Watchlist?